Galactosemia pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
In unborn children with galactosemia, galactose-1-phosphate or [[gal-1-P]] is not well metabolised and accumulates in the fetus. After birth, it accumulates in various tissues after lactose is ingested. If successfully treated, individuals with galactosemia will retain a low level of red cell gal-1-P. These levels will increase if they ingest lactose again | |||
==Pathophysiology== | ==Pathophysiology== |
Revision as of 01:18, 30 December 2013
Galactosemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Galactosemia pathophysiology On the Web |
American Roentgen Ray Society Images of Galactosemia pathophysiology |
Risk calculators and risk factors for Galactosemia pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dayana Davidis, M.D. [2]
Overview
In unborn children with galactosemia, galactose-1-phosphate or gal-1-P is not well metabolised and accumulates in the fetus. After birth, it accumulates in various tissues after lactose is ingested. If successfully treated, individuals with galactosemia will retain a low level of red cell gal-1-P. These levels will increase if they ingest lactose again